CENTERA-2: Safety and Performance Study of the Edwards CENTERA-EU Self-Expanding Transcatheter Heart Valve

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 203 participants.

Also called NCT02458560

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 203 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02458560
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Australia, Denmark, France, Germany, Italy, Netherlands, New Zealand, Switzerland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02458560. Allocation not applicable; no masking; primary purpose treatment. Start 2015-03 (actual); primary completion 2016-08-22 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CENTERA-2: Safety and Performance Study of the Edwards CENTERA-EU Self-Expanding Transcatheter Heart Valve
Condition
Aortic Valve Disease
Intervention (Device)
Edwards CENTERA Self-Expanding Transcatheter Heart Valve
Lead sponsor
Edwards Lifesciences (class: industry)
Collaborator
Medstar Health Research Institute (class: other)
Collaborator
European Cardiovascular Research Center (class: research network)
Collaborator
University of British Columbia (class: other)

Record details

Record id
cardio:ct-nct02458560
Content hash
079d9bf75abfa514e07b2d28af1ff068843ddf024466261130c6285eecc649da